Concepedia

Katherine Robinson

KR

Statistics

Publications

28

Citations

3K

H-Index

17

Active since

1993

Affiliations

Dalhousie University(Current)

Queen Elizabeth II Health Sciences Centre

Georgetown University

University of British Columbia

Ottawa Hospital

Katherine Robinson is an author at Dalhousie University specializing in medicine, rituximab-based therapy, and non-hodgkin lymphoma treatment.

Publications per year

1993–2022

28

Publications

28

Value of assessment of pretest probability of deep-vein thrombosis in clinical management

Philip S. Wells, David R. Anderson, Janis Bormanis et al. · The Lancet · 1997 · 1.2K citations

, , +15

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

Katherine Robinson, Michael E. Williams, Richard H. van der Jagt et al. · Journal of Clinical Oncology · 2008 · 352 citations

, , +13

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

Jonathan W. Friedberg, Philip Cohen, Ling Chen et al. · Journal of Clinical Oncology · 2008 · 298 citations · Full text

, , +15

Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma

Brad S. Kahl, Nancy L. Bartlett, John P. Leonard et al. · Cancer · 2009 · 246 citations · Full text

, , +14

Ultrasonographic Screening before Hospital Discharge for Deep Venous Thrombosis after Arthroplasty: The Post-Arthroplasty Screening Study: A Randomized, Controlled Trial

Katherine Robinson · Annals of Internal Medicine · 1997 · 165 citations

, , +17

1–5 of 28